New Antiviral, Antibacterial and Antifungal Agents

Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.

  • Mechanisms of action, preclinical data & pharmacology
  • Pharmacokinetics/pharmacodynamics
  • Clinical trials
  • Pharmacoepidemiology
  • New technologies in the development
  • Prescribing Improved agents
  • Advancement

Related Conference of New Antiviral, Antibacterial and Antifungal Agents

May 11-12, 2017

4th International congress on Infectious Diseases

Barcelona, Spain
August 21-23, 2017

3rd Annual Congress on Infectious Diseases

San Francisco, California, USA
September 04-05, 2017

Global Experts Meeting on Sexually Transmitted Diseases

Macau, Hong Kong
September 7-9, 2017

6thEuro-Global Conference on Infectious Diseases

Paris, France
September 13-14, 2017

6th Annual Bacteriology and Parasitology Meeting

Singapore
October 30-November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs


(10 Plenary Forums - 1 Event)
San Antonio, Texas, USA

New Antiviral, Antibacterial and Antifungal Agents Conference Speakers

Recommended Sessions

Related Journals

Are you interested in